Preclinical drug development CRO
for small molecules, peptides, and antibodies.
Arrow icon

Your partner, outside the box

We’re focused on reaching YOUR BreakThrough moments, not just selling boxed solutions. That’s why we’re with you, side-by-side, bringing creative problem-solving, custom milestone-based development, and dedicated project management.

We work with biotech companies, academic startups and venture firms developing preclinical therapeutic assets ranging from drug discovery, lead candidate selection, lead optimization and IND enabling studies.

Whether you have an ad-hoc experiment or multiple preclinical studies in the pipeline, our team is ready to help you Break•Through to your next milestone.


ONE partner to help reach your next BreakThrough.

Radyus works with biotech companies, venture funds, and academic spinouts on a path to IND. Our purpose is to be a trusted single source R&D partner, turning ideas in the lab into reality.



See how we've helped our clients move their pre-clinical drug assets closer to the clinic.


Your Team

Our industry experience makes us a one-stop solution for any pre-clinical drug development need.


Start here to reach your BreakThrough

Not sure where to start, what it costs, or what experiment to do next? Schedule a complementary 20-minute call with our team and take the first step toward your BreakThrough moment.

Email us to request your free consult.


Radyus Research Appoints Anna Walz to its Board of Directors

April 27, 2023